Clinical trial
The Effect of Nexium on Transmucosal Esophageal Leak
NCT00216788 · Main Line Health, Other · Unknown status
Key facts
| NCT number | NCT00216788 |
|---|---|
| Title | The Effect of Nexium on Transmucosal Esophageal Leak |
| Official title | The Effect of Proton Pump Inhibitors on Transmucosal Esophageal Leak |
| Lead sponsor | Main Line Health, Other |
| Collaborators | AstraZeneca Industry Sharpe-Strumia Research Foundation Cancer Research Foundation of America |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Reflux, Esophagitis, Barrett's Esophagus |
| Intervention type | Drug |
| Interventions | Esomeprazole (Nexium) 40 mg/day |
| Enrollment | 35 |
| Start date | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Mar 16, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: